ESC 365 - Why do we still not have cardioprotective drugs on the market?

HFA Premium Access

Why do we still not have cardioprotective drugs on the market?

Session: Myocardial protection and regeneration: can we change the balance in heart failure?

Topic: Myocarditis

Speaker: Professor P. Ferdinandy (Budapest, HU)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Professor Peter Ferdinandy

Semmelweis University, Budapest (Hungary)

11 presentations

1 follower

3 more presentations in this session

What is wrong with cardiac conditioning in clinical practice?

Speaker: Professor E. Iliodromitis (Athens, GR)

Lessons learned from recent trials.

Speaker: Professor D. Yellon (London, GB)

Determinants of heart failure after myocardial infarction.

Speaker: Professor M. Ovize (Lyon, FR)

Access the full session

Myocardial protection and regeneration: can we change the balance in heart failure?

Speakers: Professor P. Ferdinandy, Professor E. Iliodromitis, Professor D. Yellon, Professor M. Ovize

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources